Carmelo Nucera, M.D., Ph.D.
Harvard Medical School, and Beth Israel Deaconess Medical Center
Boston, Massachusetts
For the project “Targeting BRAF V600E with an Orally Available Selective Inhibitor in Novel In Vitro and In Vivo Preclinical Models of Human Papillary Thyroid Cancer.”